Prognostic significance of TP53 alterations in breast carcinoma
1993 · British Journal of Cancer · 167 citations
https://doi.org/10.1038/bjc.1993.383
J
J. M. Nesland
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
3.7K
Citations
32
h-index
50
i10-index
J. M. Nesland is an academic researcher from University of Oslo. The author has contributed to research in topics: Cancer-related Molecular Pathways & Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies. The author has an h-index of 32, co-authored 55 publications.
Papers by this author
worksExpression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
2004 · British Journal of Cancer · 161 citations
https://doi.org/10.1038/sj.bjc.6601536
Pregnancy and breast cancer: a population-based study
2003 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 107 citations
https://doi.org/10.1007/s00428-003-0817-z
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium.
2007 · PubMed · 31 citations
https://doi.org/10.14670/hh-22.349
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
1993 · British Journal of Cancer · 21 citations
https://doi.org/10.1038/bjc.1993.388
Expression of c‐erbB‐2 protein, neuron‐specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
1993 · Histopathology · 11 citations
https://doi.org/10.1111/j.1365-2559.1993.tb00131.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat